Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1172396Generated: November 4, 2026

Hydrochloric Acid → HCID 135949487, compound

https://huagongshe.com/reaction/1172396

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
Reactant4-MethylmorpholineHCID 7972—
ReactantSodium hydrideHCID 24758—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
Reactant2H-1,2,4-Benzothiadiazine-3-acetic acid, 7-[(methylsulfonyl)amino]-, 1,1-dioxideHCID 24858539—
ReactantHCID 57446166HCID 57446166—
SolventDimethylformamideHCID 6228—
ProductHCID 135949487HCID 135949487—

Reaction Conditions

Temperature25 °C

Reaction Steps

A solution of 2,5-dimethyl-2-pyrrolidin-2-yl-hexanoic acid ethyl ester (266 mg, 1.1 mmol), (7-methanesulfonylamino-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-acetic acid (367 mg, 1.1 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (274 mg, 1.43 mmol) in N,N-dimethylformamide (8 mL) was treated with N-methylmorpholine (289 mg, 2.86 mmol) and stirred for 1 h. The reaction was quenched with 1.0 M aqueous hydrochloric acid solution, extracted with ethyl acetate, dried over magnesium sulfate, filtered and concentrated in vacuo. The crude oil was dissolved in ethanol, treated with a 60% oil dispersion of sodium hydride (176 mg, 7.33 mmol) and heated to a vigorous reflux for 48 h. Upon cooling to 25° C., the reaction mixture was over ice in a 1.0 M aqueous hydrochloride solution. The resulting precipitate was collected by vacuum filtration to afford the crude product as a tan solid. The crude residue was purified by prep-HPLC to afford two separate diastereomers of the desired product, N-{3-[7-hydroxy-8-methyl-8-(3-methyl-butyl)-5-oxo-1,2,3,5,8,8a-hexahydro-indolizin-6-yl]-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide, as tan solids. Assignment of the relative or absolute configuration of the stereocenters was not attempted. Diasteromer 1 (122 mg, 22%): 1H NMR (400 MHz, CD2Cl2) δ: 0.84-0.90 (6H, m), 1.27 (3H, s), 1.84-2.20 (2H, m), 3.07 (3H, s), 3.50-3.58 (1H, m), 3.64-3.70 (1H, m), 3.90-3.95 (1H, m), 5.34 (2H, d, J=1.6 Hz), 6.83 (1H, s), 7.25-7.28 (1H, m), 7.54-7.58 (1H, m), 7.66-7.68 (1H, m), 14.22 (1H, s). LC-MS (ESI) calcd for C22H30N4O6S2 510.16, found 511.4 [M+H+]. Diasteromer 2 (67 mg, 12%): 1H NMR (400 MHz, CD2Cl2) δ: 0.93-0.97 (6H, m), 1.14 (2H, s), 1.22-1.45 (3H, m), 1.52-1.60 (1H, m), 1.83-2.19 (5H, m), 3.06 (3H, s), 3.42-3.59 (1H, m), 3.76-3.96 (2H, m), 5.34 (1H, s), 6.93-6.94 (1H, m), 7.27 (1H, d, J=8.8 Hz), 7.56-7.59 (1H, m), 7.66-7.69 (1H, m), 14.30 (1H, bs), 15.27 (1H, s). LC-MS (ESI) calcd for C22H30N4O6S2 510.16, found 511.4 [M+H+].

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07834009B2
Source datasetuspto-grants-2010_11
ORD IDord-b7234c0c5810401c91d6237b16c86ecb
Source noteuspto-grants-2010_11